The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
AstraZeneca (AZN) appears to be stepping back from combination therapy approaches in transthyretin amyloid cardiomyopathy following a significant phase 3 clinical failure. The setback involved Wainua, a drug developed in partnership with
More
The American Chemical Society (ACS) has announced the winners of its 2026 Green Chemistry Challenge Awards, recognising pioneering work across pharmaceuticals, materials science, agriculture, and semiconductor manufacturing. ACS says the awards “recognize
More
Major Wall Street banks are pushing large law firms to slash their fees, arguing that artificial intelligence tools can absorb significant portions of traditional legal work. The Financial Times reported that investment
More
London stocks retreated on Tuesday following a long weekend, with the FTSE 100 closing down 0.29% as investors confronted a combination of domestic inflation pressures and fresh Middle East tensions. The conflict
More
Lost Village, the Lincolnshire-based festival, is being dubbed the “Wilderness of the north” by insiders who know both events well. While Wilderness in the Cotswolds famously offers a nanny service, Lost Village
More
The pharmaceutical industry faces mounting pressure as blockbuster drug patents expire, opening markets to both generic and biosimilar competitors across the globe. Patent cliffs represent moments when brand-name drug manufacturers lose exclusivity,
More
Consumer protection has never been a red-state or blue-state issue, yet policymakers frequently treat financial safeguards as a matter of partisan preference rather than practical necessity. When an injured consumer struggles to
More
The Supreme Court has determined that no party holds legal standing to challenge a president seeking to demolish a national monument without congressional approval. The ruling effectively clears a path for executive
More
Euro zone inflation climbed back above 3% in August, driven by surging energy prices linked to the ongoing Iran war and its disruption of global supply chains. Headline inflation in the euro
More
Emergent BioSolutions (NYSE: EBS) is ramping up its opioid overdose education efforts across North America in recognition of International Overdose Awareness Day. The company is targeting college campuses across the United States
More